Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?

Abstract

This study aimed to explore inflammatory biomarkers, stool's functional bacterial groups and their possible link to portal vein thrombosis (PVT) in patients with liver cirrhosis (LC). Materials and Methods: An observational study of 300 participants: 200 inhospital cirrhotic patients, who met inclusion criteria, equally assigned into two groups, based on the presence or absence of PVT and 100 healthy controls was carried out. Results:The PVT group displayed significant differences related to older age, cigarettes smoking history, emergency admission, higher Child-Pugh score, metabolic related disorders and nonalcoholic fatty liver disease, as well as non-obstructive aspects, with chronic thrombi. The PVT group exhibited significant differences related to biomarkers such as tumor necrosis factor (TNF)-alpha, C-reactive protein (CRP), D-dimers (D-D), as well as gut overall dysbiosis (DB) and alteration of different functional bacterial groups of the gut microbiota. Strong positive correlations were observed between PVT severity, and TNF-alpha, CRP, D-D as well as lipopolysaccharide (LPS) positive bacteria. Esophageal varices, age and abdominal pain were independent predictors for PVT severity as well as CRP, TNF-alpha and D-D. Conclusion: Patients with LC and PVT displayed elevation of TNF-alpha, CRP, D-D alterations of the functional gut microbiota, as well as several morphological and clinical particularities. Although the LPS positive gut microbiota was linked to inflammatory biomarkers and PVT severity, it was not proven to be an independent predictor of the PVT severity like CRP, TNF-alpha and D-D.

Cholesterol Gallstones and Long-Term Use of Statins: Is Gut Microbiota Dysbiosis Bridging over Uncertainties?

“…Over the past decades, many studies have emphasized the association between dysbiosis and various digestive conditions, either functional or organic [ 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 ]. GSD is one of many digestive diseases that are frequently associated with gut microbiota dysbiosis, either in humans or in experimental animal models.…”

Assessing Changes in Colon Cancer Care during the COVID-19 Pandemic: A Four-Year Analysis at a Romanian University Hospital

“…However, elective surgical procedures increased by 113.6% in P3 compared to P1 and by approximately 40% compared to P2. While some studies reported no change in the proportion of patients operated on electively or as emergencies [18], most indicated a significant increase in the proportion of emergency surgeries during the pandemic [12,19,[22][23][24][25]. In this regard, Shinkwin reported an emergency presentation rate of 36% [26], while percentages as high as 53.4%, have been reported as well [27].…”

Comparative Analysis of Antibiotic Resistance in Acute Cholangitis Patients with Stent Placement and Sphincterotomy Interventions

“…The mortality rate for acute cholangitis can vary based on a number of factors, including the severity of the condition, the timeliness of treatment, and underlying patient health factors, ranging between 1 and 10% with prompt treatment [2,3]. The higher severity end can typically reach mortality rates as high as 50%, being associated with multiple comorbidities or failure to perform biliary drainage [4][5][6][7]. Globally, acute cholangitis represents a major challenge, primarily precipitated by biliary obstruction from gallstones or malignancy.…”